Skip to main content
. 2013 Sep 4;89(3):507–515. doi: 10.4269/ajtmh.13-0005

Table 2.

Comparison of TST results: 1990 and 2005 vs. 2012

TST Result Getchell and others, 199213 Pelly and others, 200511 Martinez and others, 2013 (Reference)
n Negative(0–4 mm) Borderline(5–9 mm) Positive(≥ 10 mm) P value vs. 2012 n Negative(0–4 mm) Borderline(5–9 mm) Positive(≥ 10 mm) P value vs. 2012 n Negative(0–4 mm) Borderline(5–9 mm) Positive(≥ 10 mm)
Age group
 5–14 years 89 56 (62.9) 13 (14.6) 20 (22.4) 0.04* 103 55 (53.4) 31 (30.1) 17 (16.5)
 15–24 years 58 16 (27.6) 7 (12.1) 35 (60.4) < 0.01** 35 23 (65.7) 0 (0.0) 12 (34.3) < 0.01** 67 25 (37.3) 19 (28.4) 23 (34.3)
 ≥ 25 years 72 16 (22.2) 7 (9.7) 49 (68.1) 0.25 68 18 (26.5) 7 (10.3) 43 (63.2) 0.08 258 38 (14.7) 36 (14.0) 184 (71.3)
All 219 88 (40.1) 27 (12.3) 104 (47.5) < 0.01** 103 41 (39.8) 7 (6.8) 55 (53.4) < 0.01** 428 118 (25.6) 86 (20.1) 224 (52.3)

Figures are number of participants per age category (%).

*

P < 0.05.

**

P < 0.01.

P values refer to the comparison between the age-specific prevalences of each of the tuberculin skin test (TST) result categories reported by Martinez and others, 2012 (reference) and those reported by Getchell and others, 199213 and Pelly and others, 2005,11 respectively.

TST= tuberculin skin test.

Only two participants did not have Bacille Calmette-Guérin (BCG) scars (0.05%), of whom one had a negative TST (50%) and the other had a positive TST (50%). Because of the small number of observations, we did not further stratify the TST results by number of BCG scars (0 vs. ≥ 1 BCG scar).